Literature DB >> 7899557

Comparison of relative changes in phosphatic metabolites and phospholipids after irradiation.

T E Merchant1, A A Alfieri, T Glonek, J A Koutcher.   

Abstract

Measurements of phosphatic metabolites and phospholipids using 31P NMR spectroscopy were performed on tumor extracts at specific times before and after a priming dose of radiation at 32 or 65 Gy. At both doses, statistically significant increases in the high-energy phosphates PCr and ATP, relative to their primary hydrolysis product Pi, were detected at 24 h after irradiation. These spectral changes are consistent with an increased capacity for aerobic metabolism and oxidative phosphorylation. The changes coincide with a significant reduction in the hypoxic cell fraction and 50% tumor control dose measurements reported previously for the same tumor model. A significant increase in the ratio of phosphorylethanolamine to phosphorylcholine was also detected at 24 h. The ratio of ethanolamine-containing to choline-containing phospholipids increased significantly between 48 and 96 h. The spectral changes measured in this study coincide with the changes in the hypoxic state of the tumor after irradiation and are consistent with spectral measurements performed in vivo. The high-resolution spectroscopic data also identify specific metabolites contributing to spectral changes measured in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7899557

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  2 in total

1.  Effect of radiotherapy and chemotherapy on composition of tumor membrane phospholipids.

Authors:  J C Street; J A Koutcher
Journal:  Lipids       Date:  1997-01       Impact factor: 1.880

2.  Study of radiation induced changes of phosphorus metabolism in mice by (31)P NMR spectroscopy.

Authors:  Igor Sersa; Simona Kranjc; Gregor Sersa; Alenka Nemec-Svete; Bojan Lozar; Ana Sepe; Jernej Vidmar; Marjeta Sentjurc
Journal:  Radiol Oncol       Date:  2010-09-09       Impact factor: 2.991

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.